1153 related articles for article (PubMed ID: 517244)
21. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
[TBL] [Abstract][Full Text] [Related]
22. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
Oliver JA; Vinci JM; Bowden RE; Weinberger AB; Baer L; Keiser HR; Cannon PJ
Nephron; 1981; 29(3-4):110-6. PubMed ID: 7035981
[TBL] [Abstract][Full Text] [Related]
23. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
[TBL] [Abstract][Full Text] [Related]
24. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
[TBL] [Abstract][Full Text] [Related]
25. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
Johnston CI; Matthews PG; Dax E
Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E synthesis in the kidney in renin subgroups of essential hypertension.
Sato K; Abe K; Sato M; Haruyama T; Yasujima M; Hiwatari M; Tajima J; Kasai Y; Chiba S; Seino M; Yoshinaga K
Prostaglandins Leukot Med; 1982 Nov; 9(5):577-85. PubMed ID: 6757970
[TBL] [Abstract][Full Text] [Related]
27. Furosemide-induced alterations in the electrolyte status, the function of renin-angiotensin-aldosterone system, and the urinary excretion of prostaglandins in newborn infants.
Sulyok E; Varga F; Németh M; Tényi I; Csaba IF; Ertl T; Györy E
Pediatr Res; 1980 May; 14(5):765-8. PubMed ID: 6992087
[TBL] [Abstract][Full Text] [Related]
28. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids.
Nasjletti A; McGiff JC; Colina-Chourio J
Circ Res; 1978 Nov; 43(5):799-807. PubMed ID: 309362
[TBL] [Abstract][Full Text] [Related]
29. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
Handa M; Kondo K; Suzuki H; Saruta T
Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
[TBL] [Abstract][Full Text] [Related]
30. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
[TBL] [Abstract][Full Text] [Related]
31. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
[TBL] [Abstract][Full Text] [Related]
32. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
[TBL] [Abstract][Full Text] [Related]
33. [The long-term effects of a new converting enzyme inhibitor, delapril hydrochloride, on renal function, renin-angiotensin-aldosterone system and kallikrein-kinin prostaglandin system in hypertensive patients].
Nishiyama K; Igari T; Nanba S; Ishii M
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):801-7. PubMed ID: 2273596
[TBL] [Abstract][Full Text] [Related]
34. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
[No Abstract] [Full Text] [Related]
35. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
[TBL] [Abstract][Full Text] [Related]
36. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
[No Abstract] [Full Text] [Related]
37. Implication of renal prostaglandin E in urinary sodium excretion.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Seino M; Imai Y; Saito K; Sakurai Y; Ito T; Haruyama T; Ritsu K; Yoshinaga K
Jpn Circ J; 1978 May; 42(5):565-9. PubMed ID: 702774
[TBL] [Abstract][Full Text] [Related]
38. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
[TBL] [Abstract][Full Text] [Related]
39. Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.
Maeda H; Sasaguri M; Sakai T; Kinoshita A; Koga M; Noda K; Tsuji E; Ideishi M; Arakawa K
Hypertens Res; 2000 Sep; 23(5):511-9. PubMed ID: 11016807
[TBL] [Abstract][Full Text] [Related]
40. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
